Arch Therapeutics, Inc. (ARTH) Starts Presentation at LD Micro Conference

Arch Therapeutics, Inc., a medical device company, is developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. The company is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch’s flagship development stage product candidate, the AC5 Surgical Hemostatic Device, is being designed to achieve hemostasis in minimally invasive and open surgical procedures. For more information, visit the company’s website at www.archtherapeutics.com.